APA

Kakimi K., Lane T. E., Wieland S., Asensio V. C., Campbell I. L., Chisari F. V. & Guidotti L. G. (20020114). Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. : The Journal of experimental medicine.

Chicago

Kakimi K, Lane T E, Wieland S, Asensio V C, Campbell I L, Chisari F V and Guidotti L G. 20020114. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. : The Journal of experimental medicine.

Harvard

Kakimi K., Lane T. E., Wieland S., Asensio V. C., Campbell I. L., Chisari F. V. and Guidotti L. G. (20020114). Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. : The Journal of experimental medicine.

MLA

Kakimi K, Lane T E, Wieland S, Asensio V C, Campbell I L, Chisari F V and Guidotti L G. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. : The Journal of experimental medicine. 20020114.